China Resources Pharmaceutical Group Past Earnings Performance
Past criteria checks 2/6
China Resources Pharmaceutical Group has been growing earnings at an average annual rate of 0.9%, while the Pharmaceuticals industry saw earnings growing at 8.5% annually. Revenues have been growing at an average rate of 7.7% per year. China Resources Pharmaceutical Group's return on equity is 8.8%, and it has net margins of 1.6%.
Key information
0.9%
Earnings growth rate
0.9%
EPS growth rate
Pharmaceuticals Industry Growth | 6.0% |
Revenue growth rate | 7.7% |
Return on equity | 8.8% |
Net Margin | 1.6% |
Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How China Resources Pharmaceutical Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 23 | 267,330 | 4,160 | 27,170 | 0 |
31 Mar 23 | 260,718 | 4,154 | 26,356 | 0 |
31 Dec 22 | 254,106 | 4,147 | 25,542 | 0 |
30 Sep 22 | 251,071 | 4,252 | 25,181 | 0 |
30 Jun 22 | 248,035 | 4,356 | 24,820 | 0 |
31 Mar 22 | 242,421 | 4,062 | 24,306 | 0 |
31 Dec 21 | 236,806 | 3,769 | 23,792 | 0 |
30 Sep 21 | 231,165 | 3,463 | 23,741 | 0 |
30 Jun 21 | 225,523 | 3,158 | 23,690 | 0 |
31 Mar 21 | 212,973 | 3,228 | 22,651 | 0 |
31 Dec 20 | 200,423 | 3,297 | 21,611 | 0 |
30 Sep 20 | 196,171 | 3,063 | 21,842 | 0 |
30 Jun 20 | 191,918 | 2,828 | 22,073 | 0 |
31 Mar 20 | 198,186 | 3,057 | 23,242 | 0 |
31 Dec 19 | 204,454 | 3,286 | 24,411 | 0 |
30 Sep 19 | 201,163 | 4,025 | 24,111 | 0 |
30 Jun 19 | 197,871 | 4,763 | 23,810 | 0 |
31 Mar 19 | 193,780 | 4,370 | 23,472 | 0 |
31 Dec 18 | 189,689 | 3,978 | 23,134 | 0 |
30 Sep 18 | 186,612 | 3,950 | 22,271 | 0 |
30 Jun 18 | 183,535 | 3,922 | 21,407 | 0 |
31 Mar 18 | 178,034 | 3,703 | 19,761 | 0 |
31 Dec 17 | 172,532 | 3,483 | 18,116 | 0 |
30 Sep 17 | 168,180 | 3,239 | 16,761 | 0 |
30 Jun 17 | 163,827 | 2,996 | 15,407 | 0 |
31 Mar 17 | 160,266 | 2,909 | 15,118 | 0 |
31 Dec 16 | 156,705 | 2,821 | 14,830 | 0 |
30 Sep 16 | 153,813 | 2,513 | 14,577 | 0 |
30 Jun 16 | 150,921 | 2,204 | 14,325 | 0 |
31 Mar 16 | 148,744 | 2,527 | 14,141 | 0 |
31 Dec 15 | 146,568 | 2,850 | 13,956 | 0 |
31 Dec 14 | 135,749 | 2,646 | 12,446 | 0 |
31 Dec 13 | 116,951 | 2,640 | 11,845 | 0 |
Quality Earnings: CRPG.F has high quality earnings.
Growing Profit Margin: CRPG.F's current net profit margins (1.6%) are lower than last year (1.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CRPG.F's earnings have grown by 0.9% per year over the past 5 years.
Accelerating Growth: CRPG.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CRPG.F had negative earnings growth (-4.5%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-15.2%).
Return on Equity
High ROE: CRPG.F's Return on Equity (8.8%) is considered low.